Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 03 Feb 2017
At a glance
- Drugs WASp gene therapy (Primary)
- Indications Wiskott-Aldrich syndrome
- Focus Adverse reactions; Therapeutic Use
- 31 Jan 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Jul 2017.
- 31 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Apr 2017.